Atlas Trials

Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT01083589 · COMPLETED

Trial details

NCT number
NCT01083589
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2005-01-01
Primary completion
2007-10-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.